Functional traits of trees on and off termite mounds:Understanding the origin of biotically-driven heterogeneity in savannas

Questions In African savannas, Macrotermes termites contribute to small-scale heterogeneity by constructing large mounds. Operating as islands of high nutrient and water availability and low fire frequency, these mounds support distinct, diverse communities of trees that have been shown to be highly attractive to browsers. However, the distinct traits of tree species on termite mounds have hardly been studied, even though this may help to understand processes determining (1) their characteristic community structure and (2) attractiveness for browsers. Here, we compare functional trait and browser preference values between tree species on and off termite mounds. Location Hluhluwe-iMfolozi Park, Kwazulu-Natal, South Africa. Methods We recorded tree community compositions for 16 large Macrotermes natalensis mounds and 16 control plots of 100 m2 each in a paired design. For each observed tree species we measured 22 traits, related to water and nutrient use, fire tolerance, light competition and anti-herbivore defence, and compared average trait values between mound and control communities. Furthermore, we investigated the feeding preferences of ungulate browsers for the most common tree species and how this was linked to their associated traits. Results Termite mounds supported tree communities that were distinct from the surrounding savanna vegetation. Mounds hosted more evergreen and less leguminous tree species than control communities, and the dominant species were less mechanically defended, less nutritious, had larger leaves and lower wood density than the species dominating control plots. Browsers preferred leguminous tree species with high leaf N and P content, which were relatively rare on termite mounds. Conclusions Overall, we conclude that termite mounds in this savanna form small refuges for tree species that seem less adapted to fire (more evergreens), have low nutrient availability (less nitrogen fixers) and suffer from water stress (larger leaf sizes) than typical savanna trees. Surprisingly, despite their reputation as browsing hotspots, the tree species dominating mounds are less nutritious and less preferred by browsers than tree species of the surrounding savanna, which may be explained by the relatively nutrient-rich nature of this savanna or intraspecific trait differences

Preventive use of nitisinone in alkaptonuria

Abstract Alkaptonuria (AKU, OMIM 203500) is a rare congenital disorder caused by a deficiency of the enzyme homogentisate-1,2,-dioxygenase. The long-term consequences of AKU are joint problems, cardiac valve abnormalities and renal problems. Landmark intervention studies with nitisinone 10 mg daily, suppressing an upstream enzyme activity, demonstrated its beneficial effects in AKU patients with established complications, which usually start to develop in the fourth decade. Lower dose of nitisinone in the range of 0.2–2 mg daily will already reduce urinary homogentisic acid (uHGA) excretion by > 90%, which may prevent AKU-related complications earlier in the course of the disease while limiting the possibility of side-effects related to the increase of plasma tyrosine levels caused by nitisinone. Future preventive studies should establish the lowest possible dose for an individual patient, the best age to start treatment and also collect evidence to which level uHGA excretion should be reduced to prevent complications

Letter to the editor concerning the article “Relationship between school rhythm and physical activity in adolescents: the HELENA study” by Vanhelst et al. (

Recently Vanhelst et al. published a study on the relationship between school rhythm and physical activity patterns in European adolescents in the Journal of Sports Sciences. With this Letter to the Editor we would like to comment on the practical implementation and further perspectives of the study

Relationship between serum B12 concentrations and mortality:experience in NHANES

BACKGROUND: There is conflicting evidence in the literature on the association between (elevated) serum B12 concentrations and subsequent disease or mortality. We evaluated in the NHANES general population the association of serum B12 concentrations as well as vitamin B12 supplement intake with all-cause, cardiovascular, and cancer-related mortality, while taking into account demographic and lifestyle factors and significant other diseases which are known to be associated with poorer outcome. METHODS: The main outcomes of our study were all-cause mortality, cardiovascular mortality, and cancer-related mortality. Mortality status and cause of death were determined by NHANES-linked National Death Index public access files through December 31, 2015. The association of serum B12 concentrations and vitamin B12 supplement intake with mortality was assessed with Cox proportional hazard (PH) models, with adjustment for a number of relevant demographic and lifestyle factors and comorbidity. RESULTS: The final study population of 24,262 participants had a mean age of 48 (SD 19) years; 50.1% were males. The median follow-up duration was 109 months (range 1-201 months). On the census day of December 31, 2015, 3023 participants were determined as deceased (12.5%). The fully adjusted Cox PH model indicated that low serum B12 concentrations  700 pmol/l were associated with an increase in cardiovascular mortality only (HR 1.45, 95% CI 1.01-2.06, p = 0.042). Participants with a diagnosis of hypertension, dyslipidemia, CVD, and cancer more frequently used vitamin B12-containing supplements than those without these diagnoses. We could not demonstrate an association between vitamin B12 supplement intake and mortality, when adjusted for comorbidity. CONCLUSIONS: In the general population of NHANES, low serum B12 concentrations were associated with a moderate increase in all-cause mortality. There was a small but significant increase in cardiovascular mortality in the groups with low or high serum B12. High intake of vitamin B12 in the form of supplements was not associated with any adverse effect on mortality and therefore can be regarded as safe

Increased allocation to reproduction reduces future competitive ability in a burying beetle

1. The existence of a trade-off between current and future reproduction is a fundamental prediction of life-history theory. Support for this prediction comes from brood size manipulations, showing that caring for enlarged broods often reduces the parent's future survival or fecundity. However, in many species, individuals must invest in competing for the resources required for future reproduction. Thus, a neglected aspect of this trade-off is that increased allocation to current reproduction may reduce an individual's future competitive ability. 2. We tested this prediction in the burying beetle, Nicrophorus vespilloides, a species where parents care for their offspring and where there is fierce competition for resources used for breeding. 3. We manipulated reproductive effort by providing females with either a small brood of 10 larvae or a large brood of 40 larvae and compared the ability of these females, and virgin females that had no prior access to a carcass, to compete for a second carcass against a virgin competitor. 4. We found that increased allocation to current reproduction reduced future competitive ability, as females that had cared for a small brood were more successful when competing for a second carcass against a virgin competitor than females that had cared for a large brood. In addition, the costs of reproduction were offset by the benefits of feeding from the carcass during an initial breeding attempt, as females that had cared for a small brood were better competitors than virgin females that had no prior access to a carcass, whilst females that had cared for a large brood were similar in competitive ability to virgin females. 5. Our results add to our understanding of the trade-off between current and future reproduction by showing that this trade-off can manifest through differences in future competitive ability and that direct benefits of reproduction can offset some of these costs. 16-Apr-2020Read me for "Data from RichardsonStephensSmiseth_JournalofAnimalEcology.csv" This data file consists of a comma separated values spreadsheet (.csv), which provides data for the effects of allocation to reproduction via brood size manipulation on future competitive ability in contests for a carcass. Each line in the spreadsheet represents an individual, experimental female. female_id – individual ID of the female. eclosion – date of eclosion. death – date of death. lifespan – number of days lived from eclosion to death. treatment_code – experimental treatment (control = no breeding attempt, ten = brood of ten larvae, forty = brood of forty larvae). won – outcome of the contest (Y = female won, N = female lost, NA = unclear). outcome_clear – was the outcome of the contest clear? (Y = yes, N = no). size – size of the female, measured as pronotum width (mm). competitor_size – size of the virgin female competitor measured as pronotum width (mm). size_difference – absolute difference in size between focal female and her competitor (mm). brood_size – number of larvae in the experimental brood at dispersal. dot – number and placement of identifying marks (1 or 2 = number of dots, L or R = left or right elytra). female_pre_mass – female mass prior to initial reproductive attempt (g). female_post_mass – female mass after initial reproductive attempt (g). female_mass_change – female mass change during initial reproductive attempt (g). brood_mass_pre – mass of the brood of larvae when cross fostered and given to the female (g). brood_mass_post – mass of the brood of larvae at dispersal from the carcass (g). breeding_carcass_mass – mass of the mouse carcass used for breeding (g). competition_carcass_mass – mass of the mouse carcass females competed for (g). Funding provided by: Natural Environment Research CouncilCrossref Funder Registry ID: http://dx.doi.org/10.13039/501100000270Award Number: NE/L002558/

The Many Faces of Cobalamin (Vitamin B12) Deficiency

Although cobalamin (vitamin B12) deficiency was described over a century ago, it is still difficult to establish the correct diagnosis and prescribe the right treatment. Symptoms related to vitamin B12 deficiency may be diverse and vary from neurologic to psychiatric. A number of individuals with vitamin B12 deficiency may present with the classic megaloblastic anemia. In clinical practice, many cases of vitamin B12 deficiency are overlooked or sometimes even misdiagnosed. In this review, we describe the heterogeneous disease spectrum of patients with vitamin B12 deficiency in whom the diagnosis was either based on low serum B12 levels, elevated biomarkers like methylmalonic acid and/or homocysteine, or the improvement of clinical symptoms after the institution of parenteral vitamin B12 therapy. We discuss the possible clinical signs and symptoms of patients with B12 deficiency and the various pitfalls of diagnosis and treatment.</p

Why we need systematic reviews and meta-analyses in the testing and assessment literature

Multivariate analysis of psychological dat

A prolonged methoxymorpholino doxorubicin (PNU-152243 or MMRDX) infusion schedule in patients with solid tumours: a phase 1 and pharmacokinetic study

The aim of this phase I study was to assess feasibility, pharmacokinetics and toxicity of methoxymorpholino doxorubicin (MMRDX or PNU-152243) administered as a 3 h intravenous infusion once every 4 weeks. Fourteen patients with intrinsically anthracycline-resistant tumours received 37 cycles of MMRDX. The first cohort of patients was treated with 1 mg m−2of MMRDX. The next cohorts received 1.25 mg m−2and 1.5 mg m−2respectively. Common toxicity criteria (CTC) grade III/IV nausea and vomiting were observed in 1/18 cycles at 1.25 mg m−2and in 2/11 cycles at 1.5 mg m−2. Transient elevation in transaminases up to CTC grade III was observed in 2/16 cycles at 1.25 mg m−2and 4/11 cycles at 1.5 mg m−2. No cardiotoxicity was observed. At 1.25 mg m−2CTC grade IV neutropenia occurred in 1/17 cycles. At 1.5 mg m−2CTC grade III neutropenia was seen in 2/7 and grade IV in 3/7 evaluable cycles. Thrombocytopenia grade III was observed in 2/9 and grade IV in 1/9 evaluable cycles. One patient treated at 1.5 mg m−2died with neutropenic fever. Therefore, dose-limiting toxicity was reached and 1.25 mg m−2was considered the maximum tolerated dose for MMRDX as 3 h infusion. No tumour responses were observed. Pharmacokinetic parameters showed a rapid clearance of MMRDX from the circulation by an extensive tissue distribution. Renal excretion of the drug and its metabolite was negligible. In conclusion, prolongation of MMRDX infusion to 3 h does not improve the toxicity profile as compared with bolus administration. © 2000 Cancer Research Campaig